Can-Fite BioPharma Ltd. (TASE:CANF) Financings
Financings
| Raise | Date |
|---|---|
| Warrant exercise of american Depositary Shares upon exercise of warrants Announced: about US$4M · US$5 a share · Warrants at US$5 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Research and development, clinical trials, working capital and general corporate purposes | Mar 4, 2026 |
| Public offering of american Depositary Shares (or pre-funded warrants) with short-term warrants Announced: about US$5M · US$0.6 a share · Warrants at US$0.6 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Research and development, clinical trials, working capital and general corporate purposes | Jul 28, 2025 |
| Registered direct offering of american Depositary Shares Announced: US$3M · US$1.2 a share · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Research and development, clinical trials, working capital and general corporate purposes | Apr 14, 2025 |